Title |
Long-term outcomes of anthroposophic treatment for chronic disease: a four-year follow-up analysis of 1510 patients from a prospective observational study in routine outpatient settings
|
---|---|
Published in |
BMC Research Notes, July 2013
|
DOI | 10.1186/1756-0500-6-269 |
Pubmed ID | |
Authors |
Harald Johan Hamre, Helmut Kiene, Anja Glockmann, Renatus Ziegler, Gunver Sophia Kienle |
Abstract |
Anthroposophic treatment includes special artistic and physical therapies and special medications. We here report an update to a previously published study of anthroposophic treatment for chronic diseases, including more patients and a longer follow up. The Anthroposophic Medicine Outcomes Study (AMOS) was a prospective observational cohort study of anthroposophic treatment for chronic indications in routine outpatient settings in Germany. Anthroposophic treatment was associated with improvements of symptoms and quality of life. Previous follow-up-analyses have been performed after 24 months or, in subgroups of patients enrolled in the period 1999-2001, after 48 months. We conducted a 48-month follow-up analysis of all patients enrolled in AMOS in the period 1999-2005. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 82 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 16 | 20% |
Student > Bachelor | 8 | 10% |
Student > Doctoral Student | 8 | 10% |
Researcher | 7 | 9% |
Student > Ph. D. Student | 5 | 6% |
Other | 13 | 16% |
Unknown | 25 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 26 | 32% |
Nursing and Health Professions | 10 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Neuroscience | 3 | 4% |
Psychology | 3 | 4% |
Other | 8 | 10% |
Unknown | 29 | 35% |